Royalty Pharma Sub-Manager, LLC
Royalty Pharma Sub-Manager, LLC reported 4 holdings worth US$242M as of Jun 30, 2026 (Form 13F/A)
As of Jun 30, 2026 · Filed Aug 21, 2026
Royalty Pharma Sub-Manager, LLC reported 4 holdings worth US$242M as of Jun 30, 2026. Largest: Cytokinetics, Incorporated, Zenas Biopharma, Inc. and Kailera Therapeutics, Inc. Filed Aug 21, 2026 (Form 13F/A).
- Holdings
- 4
- Value as reported
- US$242M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| Cytokinetics, Incorporated | 980K | US$83.5M | 34.5% |
| Zenas Biopharma, Inc. | 2.39M | US$60.6M | 25.1% |
| Kailera Therapeutics, Inc. | 2.46M | US$54.1M | 22.4% |
| Biohaven Ltd. | 2.94M | US$43.7M | 18.1% |
| Biocryst Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Bicara Therapeutics Inc. | 0 | US$0 | 0.00% |